In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Neurological Outcomes of Two-Level TDR versus ACDF: 7 year Results from a Prospective, Randomized, Multicenter Trial

    Final Number:
    159

    Authors:
    Robert Jackson MD, FACS, FAANS; Darin Eric Johnson PA

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: Studies suggest significant biomechanical and clinical differences exist between TDR and ACDF patients treated at multiple cervical levels. However, long-term results for treatment of multilevel cervical degenerative disc disease are lacking. Here we evaluate seven-year neurological and clinical outcomes of patients treated at two contiguous levels with TDR or ACDF.

    Methods: Prospective, randomized, multicenter, controlled clinical trial. The study cohort consisted of 225 patients receiving TDR and 105 patients receiving ACDF with allograft and anterior plate. Patients were treated at two contiguous levels from C3 to C7. Outcomes measured at 7 years included neurological deterioration, device-related adverse events, VAS neck and arm pain, subsequent surgeries, and range of motion. Neurological deterioration was assessed as any decrease in motor, sensory or reflex assessment.

    Results: At 7 years, 13.4% of TDR and 34.2% of ACDF patients had neurological deterioration (p=0.0002). Device-related neurological adverse events (AEs) were significantly lower for TDR (5.1% vs. 11.4%; p=0.04). Neurological adverse events were most frequently sensory related (3.0% vs. 4.8%) rather than motor (0.9% vs. 1.9%) or reflex (0.4% vs. 1.0%) neurological events. VAS neck (18.7 vs. 29.7) and arm pain (15.2 vs. 18.8) were lower in TDR patients compared to ACDF, though these differences were not statistically significant. Device-related subsequent surgeries were significantly lower for TDR (4.9% vs. 16.2%; p=0.001). Patients with TDR maintained flexion-extension range of motion at both the superior (9.4°) and inferior (7.5°) treated levels.

    Conclusions: Treatment with two-level TDR demonstrated better long-term neurological outcomes compared to ACDF. Neurological deterioration and adverse events were significantly better with TDR, with neurological events most frequently being sensory related. TDR patients had fewer subsequent surgeries and less neck and arm pain, while maintaining range of motion.

    Patient Care: We hope to provide long term results with regard to neurological deterioration, adverse events, and subsequent surgery rates for two common surgical procedures frequently utilized in the treatment of cervical degenerative disc disease.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Describe the long term results of TDR and ACDF with regard to neurological outcome and potential adverse events, 2) be familiar with 7 year subsequent surgery rates for TDR and ACDF

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy